Difference between revisions of "PCC TC Face to Face July 22 26, 2019 Minutes"

From IHE Wiki
Jump to navigation Jump to search
 
(2 intermediate revisions by the same user not shown)
Line 20: Line 20:
 
**DCP : 3 types of comments have been received  
 
**DCP : 3 types of comments have been received  
 
**CDA-DSS : comments have been received from Steve
 
**CDA-DSS : comments have been received from Steve
 
  
 
*'''Profile proposal: IPS (International Patient Summary)'''
 
*'''Profile proposal: IPS (International Patient Summary)'''
**Website [http://international-patient-summary.net/]
+
**Website [http://international-patient-summary.net/], Profile proposal [ftp://ftp.ihe.net/Patient_Care_Coordination/yr15_2019-2020/Planning%20Committee/Profile%20Proposals/IHE_PCC_IPS_Proposal_Detailed_2019-08-30.docx]
 
**Main editor : M Nusbaum, Andrea Fourquet,  
 
**Main editor : M Nusbaum, Andrea Fourquet,  
 
**Attendees: same +
 
**Attendees: same +
***In Person: Lori Fourquet, Derek,  
+
***In Person: Lori Fourquet, Derek Ritz,  
 
***Via Webex: Michael Nusbaum
 
***Via Webex: Michael Nusbaum
 
**PCC TC questions  
 
**PCC TC questions  
Line 36: Line 35:
 
***Is there any additional stake holder ?  
 
***Is there any additional stake holder ?  
 
***Who is responsible of what betwenn HL7 and IHE?
 
***Who is responsible of what betwenn HL7 and IHE?
 
  
 
== '''Tuesday July 23, 2019''' ==
 
== '''Tuesday July 23, 2019''' ==
Line 100: Line 98:
 
*'''QEDm update on FHIR R4 review and voting'''
 
*'''QEDm update on FHIR R4 review and voting'''
 
** John Moehrke (ITI) has updated QEDm profile on FHIR R4
 
** John Moehrke (ITI) has updated QEDm profile on FHIR R4
** Voting for publicatio in trial implementation: Andrea Fourquet, Michael Clifton (Epic), Tone Southerland (IQVIA), Thierry Dart (ASIP Santé)
+
** Voting for publication in trial implementation: Andrea Fourquet, Michael Clifton (Epic), Tone Southerland (IQVIA), Thierry Dart (ASIP Santé)
 
*** All in favour, no abstention
 
*** All in favour, no abstention

Latest revision as of 07:55, 12 November 2019

Monday July 22, 2019

  • Attendees
    • In Person: Michael Clifton (Epic), Tone Southerland (IQVIA), Thierry Dart (ASIP Santé)
    • Via Webex: Emma Jones (Allscripts)
  • Review Anti-trust and Patent Policy
  • Format codes
    • Format codes IHE and HL7 have their own format codes
    • There is a lot of confusion for a vendor perspective between format codes and template ID
      • Shall PCC work on a profile to manage this ?
  • Review of public comments : DCP (Dynamic Care Planning) and CDA-DSS (CDA Document Summary Sections)
    • Collect of all comments has been done by Emma Jones.
    • Comments will be reviewed on Tuesday
    • DCP : 3 types of comments have been received
    • CDA-DSS : comments have been received from Steve
  • Profile proposal: IPS (International Patient Summary)
    • Website [1], Profile proposal [2]
    • Main editor : M Nusbaum, Andrea Fourquet,
    • Attendees: same +
      • In Person: Lori Fourquet, Derek Ritz,
      • Via Webex: Michael Nusbaum
    • PCC TC questions
      • 1)Scope of workflow ?
      • 2)Benefits for vendor (risks)?
      • 3)Marketing?
    • Next steps
      • IHE PCC TC needs more detail about this proposal.
      • Is there any additional stake holder ?
      • Who is responsible of what betwenn HL7 and IHE?

Tuesday July 23, 2019

  • Attendees
    • In Person: Michael Clifton (Epic), Thierry Dart (ASIP Santé)
    • Via Webex: Emma Jones (Allscripts)
  • Review of public comments : DCP (Dynamic Care Planning) and CDA-DSS (CDA Document Summary Sections)
    • DCP public comments
      • C-01 to C08, C-10 to C-12, C-15 to C-16, C-19 to C-46: Persuasive
      • C-09, C-13, C-14, C-18, C-46: Emma needs input from Jeff
      • C-47, C-48: Non persuasive
      • C-49, C-52: Hold for now
      • C-02: Persuasive, Content modules in PCC are in Volume 2, should be Appendix D
      • C-25 to C-28: persuasive, split the use cases to simplify the diagram to include the additional subscribe transactions
    • CDA-DSS public comments
      • C-01 to C-03, C-05 to C-10: persuasive
      • C-04: non persuasive
  • IPS-International Patient Summary (Profil proposal)
    • Attendees: same +
      • In Person: Lori Fourquet, Tone Southerland (IQVIA)
    • There is a "general confusion" about the goal of the profile in a IHE perspective : is it a workflow profile ? a content profile ? a test plan ? a FHIR and CDA profile ?
    • Details proposal will be presented in two weeks during the PCC T-CONF


Wednesday July 24, 2019

  • Attendees
    • In Person: Michael Clifton (Epic), Thierry Dart (ASIP Santé)
    • Via Webex: Emma Jones (Allscripts)


  • Review of public comments : DCP (Dynamic Care Planning) and CDA-DSS (CDA Document Summary Sections)
    • DCP public comments
      • DCP public comments will be reviewed on the next PCC T-Conf, because Emma needs some inputs from Jeff and Steve.
    • CDA-DSS public comments
      • All the comments have been reviewed.


  • Profile proposal: IPS (International Patient Summary)
    • Attendees: same +
      • In Person: Lori Fourquet, Tone Southerland (IQVIA), Derek Ritz
      • Via Webed: Didi Davis, John Donnelly
    • Consensus
      • A detailed proposal is needed
      • IHE can produce, for this cycle, a very basic document with two options: test plan or content profile (a workflow approach is too large for this cycle)
      • Agenda could be : Vol1 in November 2019, Vol2 in February 2020, Review of public comments in April 2020
    • Voting session
      • 4 voting : Michael Clifton (Epic), Tone Southerland (IQVIA), John Donnelly, Thierry Dart (ASIP Santé)
      • One motion from Tone Southerland (4 in favour, 0 abstention) to have more details in a detailed proposal in a few weeks to be reviewed during PCC T-Conf (bi-weekly)


Thursday July 25, 2019

  • Joint meeting ITI, PCC, QRPH, PHARM


  • QEDm update on FHIR R4 review and voting
    • John Moehrke (ITI) has updated QEDm profile on FHIR R4
    • Voting for publication in trial implementation: Andrea Fourquet, Michael Clifton (Epic), Tone Southerland (IQVIA), Thierry Dart (ASIP Santé)
      • All in favour, no abstention